Lung Cancer Clinical Trials in Heerlen, Limburg
4 recruitingHeerlen, Limburg, Netherlands
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Bristol-Myers Squibb1,000 enrolled280 locationsNCT06561386
Recruiting
Phase 2Phase 3
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
AbbVie840 enrolled61 locationsNCT06236438
Recruiting
Implementation of Up-front ctDNA Into Lung Cancer Care and Development of Liquid Biopsy-based Decision Support Models - LM² Study
Lung Cancer
Catharina Ziekenhuis Eindhoven800 enrolled5 locationsNCT06105177
Recruiting
Lung Tumor Protein Synthesis Rates in Lung Cancer Patients
Lung Cancer
Maastricht University Medical Center30 enrolled1 locationNCT05794529